News

Insight: Hat in hand - U.S. scientists scramble to support their COVID immunity research

Insight: Hat in hand - U.S. scientists scramble to support their COVID immunity research
World
A well plate used in the early stages of development of a coronavirus disease (COVID-19) antibody test is seen at the Laboratory for Human Biology Research, Department of Anthropology at Northwestern University in Evanston, Illinois, U.S., April 19, 2020. Picture taken April 19, 2020. Thomas McDade/Handout via REUTERS NO RESALES. NO ARCHIVES. THIS IMAGE HAS BEEN SUPPLIED BY A THIRD PARTY. MANDATORY CREDIT

In April, when a key enzyme couldn’t be delivered to his shuttered laboratory, Northwestern University researcher Thomas McDade hunted for the package across the empty campus near Chicago, finally locating it at a loading dock. To verify the test’s accuracy, the biological anthropologist and his colleague, pharmacologist Alexis Demonbreun, asked friends and family if they’d be willing to spot them some blood. McDade took a sample from his wife over their kitchen table.

The scientists’ goal is to look for people with coronavirus antibodies - proteins that indicate possible immunity - in Chicago-area neighborhoods with vastly different death rates. They want to study why the novel coronavirus is deadlier for some groups, such as African Americans and Latinos.

In early May, the team arrived at a test they believed worked. “All the pieces are in place,” McDade wrote in an email to colleagues on May 20. “All we need now is funding to roll it out.”

Across the United States, academic and regional government researchers have embarked on antibody testing initiatives to determine how the coronavirus is spreading, how deadly it is and who is likely to suffer its worst effects. The results could help return the country to normalcy, scientists say, by revealing who is still susceptible and guiding prevention efforts and lockdown decisions..

Unlike clinicians focused mainly on diagnosing individual patients, these scientists study states, communities and other subgroups. But their jobs are made much harder, they say, in the absence of substantial federal funding, standards and coordination.

“It would be better to have a unified information sharing system, a unified testing strategy, and the resources to execute it everywhere in the country,” said Dr. Joe DeRisi, co-president of the Chan Zuckerberg Biohub, a medical research nonprofit in San Francisco.

Instead, the success of coronavirus antibody studies often depends on luck, personal commitment and whatever resources researchers can muster, according to Reuters interviews with more than 20 scientists, public health officials and others.

In a statement, Mia Heck, a spokeswoman for the Department of Health and Human Services, said the administration of President Donald Trump “continues to improve America’s testing capabilities and capacity. As part of these efforts, the Administration is working with diagnostics companies and academic researchers to develop the next generation of tests, testing platforms, and testing protocols. Antibody testing is a particularly important area of ongoing inquiry.”

Of the more than $35 billion allocated by the federal government for COVID-19 testing, relatively little has been earmarked for antibody testing and research. HHS has focused much more on diagnostic testing, which reveals active infections, as opposed to antibody surveillance, which seeks to identify people who have ever been infected with COVID-19, even if they showed no symptoms.

However, $306 million of the federal money has been set aside for the National Cancer Institute to expand antibody testing capacity and fund research projects, according to a public presentation last month by Dr. Dinah Singer, the institute’s deputy director of scientific strategy and development. The institute will award money to private-sector clinical researchers and academic institutions, creating a coordinating center for sharing resources and data.

The U.S. Centers for Disease Control and Prevention, which is overseen by HHS, plans to test for antibodies in 325,000 samples from blood donors in 25 major metropolitan regions over 18 months, beginning this summer.

So far, large-scale blood antibody tests, both by academic researchers and local or state governments, indicate that most people remain vulnerable to coronavirus infection. But results vary - sometimes widely.

Researchers at Massachusetts General Hospital in Boston did one study based on a street corner in a Chelsea, Massachusetts, neighborhood with high COVID-19 hospitalization rates, finding that 31.5% of people had antibodies. In another study across several Boston neighborhoods, the same researchers found 10%.

New York state has tested more than 50,000 people since April, finding antibodies in 12.3% of the population statewide but 20% in New York City, according to Jonah Bruno, a state Department of Health spokesman.

Several antibody studies have been conducted in more affluent areas, where funding was more readily available. Academics from three universities in the San Francisco Bay Area, for instance, have launched at least four antibody blood test initiatives.

In Bolinas, California, a team from the University of California, San Francisco (UCSF), tested more than 1,800 people for coronavirus and its antibodies after locals crowdfunded the cost. The isolated beach community in Marin County, one of the country’s richest, is overwhelmingly white. Diagnostic testing in April showed zero infections, and antibody testing showed between zero and 0.3% had ever been infected.

“I wouldn’t have necessarily chosen Bolinas as the one community to test,” said Dr. Matt Willis, Marin County’s public health officer.

With little standardization, some early efforts at antibody testing have proved inconsistent, onerous and of questionable quality.
Read more on reuters.com
News Topics :
Similar Articles :
World
FILE PHOTO Northwestern University Professor Thomas McDade inspects a 96 well plate used to quantify coronavirus disease COVID 19 IgG antibodies in dried blood spot samples at the Laboratory for Human Biology...
World
SAN FRANCISCO—Few if any residents of the tiny Marin County hamlet of Bolinas, Calif., have antibodies for COVID 19 , researchers reported Thursday. Residents of this isolated U.S. beach town, famously...
World
Reuters The U.S. Centers for Disease Control and Prevention CDC plans a nationwide study of up to 325, 000 people to track how the new coronavirus is spreading across the...
Science
An antibody test for the virus that causes COVID 19, developed by researchers at The University of Texas at Austin in collaboration with Houston Methodist and other institutions, is more accurate...
Top Stories
TORONTO Health Canada has approved a test that can detect antibodies specific to COVID 19 in an individual’s blood, allowing Canadian labs to take a significant step forward...